Preventing Chronic Disease | Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care - CDC

full-text ►

Preventing Chronic Disease | Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care - CDC

Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care

Navigate This Article

• Abstract
• Introduction
• Methods
• Results
• Discussion
• Acknowledgments
• Author Information
• References
• Tables

Margie E. Snyder, PharmD, MPH; Tara R. Earl, PhD, MSW; Siobhan Gilchrist, JD, MPH; Michael Greenberg, JD, MPH; Holly Heisler, MPH, MBA; Michelle Revels, MA; Dyann Matson-Koffman, DrPH, MPH, CHES

Suggested citation for this article: Snyder ME, Earl TR, Gilchrist S, Greenberg M, Heisler H, Revels M, et al. Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care. Prev Chronic Dis 2015;12:140504. DOI:http://dx.doi.org/10.5888/pcd12.140504.

PEER REVIEWED

Abstract

Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider–pharmacist collaborative drug therapy management practices and identifies the facilitators and barriers to implementing such services in community settings. We conducted in-depth, qualitative interviews in 2012 in a federally qualified health center, an independent pharmacy, and a retail pharmacy chain. Facilitators included 1) ensuring pharmacists were adequately trained; 2) obtaining stakeholder (eg, physician) buy-in; and 3) leveraging academic partners. Barriers included 1) lack of pharmacist compensation; 2) hesitation among providers to trust pharmacists; 3) lack of time and resources; and 4) existing informal collaborations that resulted in reduced interest in formal agreements. The models described in this study could be used to strengthen clinical–community linkages through team-based care, particularly for chronic disease prevention and management.

Acknowledgments

CDC funded this study. The authors gratefully acknowledge Benjamin Bluml and Lindsay Watson from the American Pharmacists Association Foundation for their assistance in identifying sites.

Top of Page

Author Information

Corresponding Author: Siobhan Gilchrist, JD, MPH, Applied Research and Evaluation Branch, Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F-72, Atlanta, GA 30341. Telephone: 770-488-8195. Email: smg0@cdc.gov.

Author Affiliations: Margie E. Snyder, Purdue University, Indianapolis, Indiana; Tara R. Earl, Michael Greenberg, Michelle Revels, ICF International, Inc, Atlanta, Georgia; Holly Heisler, ICF International, Inc, Cambridge, Massachusetts; Dyann Matson-Koffman, Office of the Associate Director for Science, Centers for Disease Control and Prevention, Atlanta, Georgia. Siobhan Gilchrist is also affiliated with IHRC, Inc, Atlanta, Georgia. At the time the study was conducted, Ms Gilchrist was affiliated with Columbus Technologies and Services, Inc, Atlanta, Georgia; Ms Heisler was affiliated with ICF International, Inc, Atlanta, Georgia; and Dr Matson-Koffman was affiliated with the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.

Top of Page

References

1. Hammond RW, Schwartz AH, Campbell MJ, Remington TL, Chuck S, Blair MM, et al. Collaborative drug therapy management by pharmacists—2003. Pharmacotherapy 2003;23(9):1210–25. PubMed
2. Carmichael JM, O’Connell MB, Devine B, Kelly HW, Ereshefsky L, Linn WD, et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy 1997;17(5):1050–61. PubMed
3. Centers for Disease Control and Prevention. State law fact sheet: select features of state pharmacist collaborative practice laws. September 2013. http://ww.cdc.gov/dhdsp/pubs/docs/Pharmacist_State_Law.PDF. Accessed January 21, 2014.
4. Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care 2010;48(10):923–33. CrossRef PubMed
5. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158(15):1641–7. CrossRef PubMed
6. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000;15(4):137–42.CrossRef PubMed
7. Community Preventive Services Task Force. Team-based care to improve blood pressure control: recommendation of the Community Preventive Services Task Force. Am J Prev Med 2014;47(1):100–2. CrossRef PubMed
8. Giberson S, Yoder S, Lee M. Improving patient and health system outcomes through advanced pharmacy practice: report to the US Surgeon General, Office of the Chief Pharmacist. Washington (DC): US Public Health Service; 2011.
9. American Pharmacists Association; National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc (2003) 2008;48(3):341–53. CrossRef PubMed
10. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc (2003) 2005;45(5):566–72.CrossRef PubMed
11. Centers for Medicare and Medicaid Services, US Department of Health and Human Services. 2005. Medicare program Medicare prescription drug benefit, final rule. 70 Fed Reg (42 C.R.F. § 423).
12. 2012 Preliminary comparative results: pharmacy survey on patient safety culture. Rockville (MD): Agency for Healthcare Research and Quality; 2012. AHRQ publication no. 12-0085-1-EF. http://www.ahrq.gov/professionals/quality-patient-safety/patientsafetyculture/pharmacy/2012/pharmsops_pilotresults.pdf. Accessed December 22, 2014.
13. National Association of Community Health Centers. United States health center fact sheet, 2012. http://www.nachc.com/client//US2014.pdf. Accessed December 22, 2014.
14. Isetts B. Evaluating effectiveness of the Minnesota Medication Therapy Management Care Program: final report to Medicaid. 2007. http://www.dhs.state.mn.us/main/groups/business_partners/documents/pub/dhs16_140283.pdf. Accessed January 29, 2014.
15. Moczygemba LR, Goode JV, Gatewood SB, Osborn RD, Alexander AJ, Kennedy AK, et al. Integration of collaborative medication therapy management in a safety net patient-centered medical home. J Am Pharm Assoc (2003) 2011;51(2):167–72. CrossRef PubMed
16. Smith M, Giuliano MR, Starkowski MP. In Connecticut: improving patient medication management in primary care. Health Aff (Millwood) 2011;30(4):646–54. CrossRef PubMed
17. Willink DP, Isetts BJ. Becoming ‘indispensable’: developing innovative community pharmacy practices. J Am Pharm Assoc (2003) 2005;45(3):376–86.CrossRef PubMed
18. American Pharmacists Association Foundation and American Pharmacists Association. Consortium recommendations for advancing pharmacists’ patient care services and collaborative practice agreements. J Am Pharm Assoc (2003) 2013;53(2):e132–41. CrossRef PubMed
19. Liu Y, Doucette WR, Farris KB. Examining the development of pharmacist-physician collaboration over 3 months. Res Social Adm Pharm 2010;6(4):324–33.CrossRef PubMed
20. Murawski M, Villa KR, Dole EJ, Ives TJ, Tinker D, Colucci VJ, et al. Advanced-practice pharmacists: practice characteristics and reimbursement of pharmacists certified for collaborative clinical practice in New Mexico and North Carolina. Am J Health Syst Pharm 2011;68(24):2341–50. CrossRef PubMed